RecallRadar

FDA Drug recall D-0632-2020

RANITIDINE TABLETS, USP 150mg, 10,000-count bag, Country of Origin: INDIA NDC 62207-773-32

On 2020-01-08 the FDA classified a Class II recall of RANITIDINE TABLETS, USP 150mg, 10,000-count bag, Country of Origin: INDIA NDC 62207-773-32 by Granules India, citing CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0632-2020
ClassificationClass II
Statusongoing
Initiated2019-12-13
Published2020-01-08
Last updated2026-09-13 11:52 UTC
CompanyGranules India
DistributionNJ, NY, OR

Product

RANITIDINE TABLETS, USP 150mg, 10,000-count bag, Country of Origin: INDIA NDC 62207-773-32

Reason

CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API

Identifiers

ndc62207-774-58
ndc62207-774-41
ndc62207-774-47
ndc62207-774-36
ndc62207-773-58
ndc62207-773-41
ndc62207-773-47
ndc62207-773-32
ndc62207-773-36
code_info7730001A, 7730002A, 7730003A, 7730004A, 7730005A, 7730006A, 7730007A, 7730008A, 7730009A, 7730010A, 7730011A and 7730012A

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0632-2020%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.